• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定ataxin-3与淀粉样蛋白聚集抑制剂多聚谷氨酰胺结合肽1之间新的相互作用位点。

Identification of a novel site of interaction between ataxin-3 and the amyloid aggregation inhibitor polyglutamine binding peptide 1.

作者信息

Knight Patrick D, Karamanos Theodoros K, Radford Sheena E, Ashcroft Alison E

机构信息

Faculty of Biological Sciences, University of Leeds, Leeds, UK.

出版信息

Eur J Mass Spectrom (Chichester). 2018 Feb;24(1):129-140. doi: 10.1177/1469066717729298. Epub 2017 Aug 29.

DOI:10.1177/1469066717729298
PMID:29334808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6134688/
Abstract

Amyloid diseases represent a growing social and economic burden in the developed world. Understanding the assembly pathway and the inhibition of amyloid formation is key to developing therapies to treat these diseases. The neurodegenerative condition Machado-Joseph disease is characterised by the self-aggregation of the protein ataxin-3. Ataxin-3 consists of a globular N-terminal Josephin domain, which can aggregate into curvilinear protofibrils, and an unstructured, dynamically disordered C-terminal domain containing three ubiquitin interacting motifs separated by a polyglutamine stretch. Upon expansion of the polyglutamine region above 50 residues, ataxin-3 undergoes a second stage of aggregation in which long, straight amyloid fibrils form. A peptide inhibitor of polyglutamine aggregation, known as polyQ binding peptide 1, has been shown previously to prevent the maturation of ataxin-3 fibrils. However, the mechanism of this inhibition remains unclear. Using nanoelectrospray ionisation-mass spectrometry, we demonstrate that polyQ binding peptide 1 binds to monomeric ataxin-3. By investigating the ability of polyQ binding peptide 1 to bind to truncated ataxin-3 constructs lacking one or more domains, we localise the site of this interaction to a 39-residue sequence immediately C-terminal to the Josephin domain. The results suggest a new mechanism for the inhibition of polyglutamine aggregation by polyQ binding peptide 1 in which binding to a region outside of the polyglutamine tract can prevent fibril formation, highlighting the importance of polyglutamine flanking regions in controlling aggregation and disease.

摘要

在发达国家,淀粉样疾病给社会和经济带来的负担日益加重。了解淀粉样蛋白的组装途径以及抑制其形成是开发治疗这些疾病疗法的关键。神经退行性疾病马查多-约瑟夫病的特征是ataxin-3蛋白的自我聚集。ataxin-3由一个球状的N端约瑟芬结构域和一个无结构、动态无序的C端结构域组成,前者可聚集成曲线状原纤维,后者包含三个由聚谷氨酰胺延伸段隔开的泛素相互作用基序。当聚谷氨酰胺区域扩展到50个以上残基时,ataxin-3会经历第二个聚集阶段,形成长的直淀粉样纤维。一种聚谷氨酰胺聚集的肽抑制剂,即聚Q结合肽1,此前已被证明可阻止ataxin-3纤维的成熟。然而,这种抑制作用的机制尚不清楚。我们使用纳米电喷雾电离质谱法证明,聚Q结合肽1与单体ataxin-3结合。通过研究聚Q结合肽1与缺失一个或多个结构域的截短ataxin-3构建体结合的能力,我们将这种相互作用的位点定位到约瑟芬结构域C端紧邻的一个39个残基的序列。这些结果提示了聚Q结合肽1抑制聚谷氨酰胺聚集的一种新机制,即与聚谷氨酰胺区域之外的一个区域结合可阻止纤维形成,突出了聚谷氨酰胺侧翼区域在控制聚集和疾病方面的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/c32b01e6b178/10.1177_1469066717729298-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/d1506b25e8af/10.1177_1469066717729298-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/57f772bde1de/10.1177_1469066717729298-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/70cdcd07bdc6/10.1177_1469066717729298-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/3bdefeaa5d7b/10.1177_1469066717729298-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/fc8e4b0184b4/10.1177_1469066717729298-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/c1c366f51191/10.1177_1469066717729298-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/f916e7094d82/10.1177_1469066717729298-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/5e10c0893f94/10.1177_1469066717729298-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/c32b01e6b178/10.1177_1469066717729298-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/d1506b25e8af/10.1177_1469066717729298-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/57f772bde1de/10.1177_1469066717729298-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/70cdcd07bdc6/10.1177_1469066717729298-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/3bdefeaa5d7b/10.1177_1469066717729298-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/fc8e4b0184b4/10.1177_1469066717729298-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/c1c366f51191/10.1177_1469066717729298-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/f916e7094d82/10.1177_1469066717729298-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/5e10c0893f94/10.1177_1469066717729298-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cee/6134688/c32b01e6b178/10.1177_1469066717729298-fig9.jpg

相似文献

1
Identification of a novel site of interaction between ataxin-3 and the amyloid aggregation inhibitor polyglutamine binding peptide 1.鉴定ataxin-3与淀粉样蛋白聚集抑制剂多聚谷氨酰胺结合肽1之间新的相互作用位点。
Eur J Mass Spectrom (Chichester). 2018 Feb;24(1):129-140. doi: 10.1177/1469066717729298. Epub 2017 Aug 29.
2
Examination of Ataxin-3 (atx-3) Aggregation by Structural Mass Spectrometry Techniques: A Rationale for Expedited Aggregation upon Polyglutamine (polyQ) Expansion.利用结构质谱技术检测ataxin-3(atx-3)聚集:聚谷氨酰胺(polyQ)扩增后加速聚集的原理
Mol Cell Proteomics. 2015 May;14(5):1241-53. doi: 10.1074/mcp.M114.044610. Epub 2015 Feb 19.
3
Enhanced molecular mobility of ordinarily structured regions drives polyglutamine disease.普通结构区域增强的分子流动性驱动聚谷氨酰胺疾病。
J Biol Chem. 2015 Oct 2;290(40):24190-200. doi: 10.1074/jbc.M115.659532. Epub 2015 Aug 10.
4
Evolutionary model of repeat insertions in Ataxin-3 traces the origin of the polyglutamine stretch to an ancestral ubiquitin binding module.Ataxin-3 中重复插入的进化模型追踪了多聚谷氨酰胺延伸的起源,追溯到一个祖先泛素结合模块。
Protein Sci. 2024 Dec;33(12):e5236. doi: 10.1002/pro.5236.
5
Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.含多聚谷氨酰胺的共济失调蛋白3的Josephin结构域的结构及淀粉样蛋白生成特性的表征
J Mol Biol. 2004 Dec 3;344(4):1021-35. doi: 10.1016/j.jmb.2004.09.065.
6
Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein.侧翼结构域稳定性调节聚谷氨酰胺疾病蛋白的聚集动力学。
Protein Sci. 2011 Oct;20(10):1675-81. doi: 10.1002/pro.698. Epub 2011 Aug 18.
7
Polyglutamine expansion diseases: More than simple repeats.多聚谷氨酰胺扩展疾病:不只是简单的重复。
J Struct Biol. 2018 Feb;201(2):139-154. doi: 10.1016/j.jsb.2017.09.006. Epub 2017 Sep 18.
8
The Machado-Joseph disease-associated form of ataxin-3 impacts dynamics of clathrin-coated pits.Machado-Joseph 病相关的 ataxin-3 形式影响网格蛋白包被凹陷的动力学。
Cell Biol Int. 2020 May;44(5):1252-1259. doi: 10.1002/cbin.11312. Epub 2020 Feb 11.
9
Mass spectrometry analyses of normal and polyglutamine expanded ataxin-3 reveal novel interaction partners involved in mitochondrial function.对正常和多聚谷氨酰胺扩展的 ataxin-3 的质谱分析揭示了涉及线粒体功能的新的相互作用伙伴。
Neurochem Int. 2018 Jan;112:5-17. doi: 10.1016/j.neuint.2017.10.013. Epub 2017 Oct 27.
10
Protein Environment: A Crucial Triggering Factor in Josephin Domain Aggregation: The Role of 2,2,2-Trifluoroethanol.蛋白质环境:约瑟夫结构域聚集的关键触发因素:2,2,2-三氟乙醇的作用。
Int J Mol Sci. 2018 Jul 24;19(8):2151. doi: 10.3390/ijms19082151.

引用本文的文献

1
Ameliorating Fibrosis in Murine and Human Tissues with END55, an Endostatin-Derived Fusion Protein Made in Plants.利用END55(一种在植物中制造的内皮抑素衍生融合蛋白)改善小鼠和人体组织中的纤维化。
Biomedicines. 2022 Nov 9;10(11):2861. doi: 10.3390/biomedicines10112861.
2
A Robust Assay to Monitor Ataxin-3 Amyloid Fibril Assembly.一种用于监测 Ataxin-3 淀粉样纤维组装的稳健分析方法。
Cells. 2022 Jun 19;11(12):1969. doi: 10.3390/cells11121969.
3
Investigating the interactions of the first 17 amino acid residues of Huntingtin with lipid vesicles using mass spectrometry and molecular dynamics.

本文引用的文献

1
Investigating the Structural Compaction of Biomolecules Upon Transition to the Gas-Phase Using ESI-TWIMS-MS.利用电喷雾串联飞行时间质谱研究生物分子在进入气相时的结构紧缩。
J Am Soc Mass Spectrom. 2017 Sep;28(9):1855-1862. doi: 10.1007/s13361-017-1689-9. Epub 2017 May 8.
2
Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.含有扩展型聚谷氨酰胺序列的蛋白质与神经退行性疾病
Biochemistry. 2017 Mar 7;56(9):1199-1217. doi: 10.1021/acs.biochem.6b00936. Epub 2017 Feb 21.
3
Sequence Context Influences the Structure and Aggregation Behavior of a PolyQ Tract.
利用质谱和分子动力学研究 Huntingtin 前 17 个氨基酸残基与脂质囊泡的相互作用。
J Mass Spectrom. 2020 Jan;55(1):e4470. doi: 10.1002/jms.4470. Epub 2019 Dec 16.
序列上下文影响聚谷氨酰胺序列的结构和聚集行为。
Biophys J. 2016 Jun 7;110(11):2361-2366. doi: 10.1016/j.bpj.2016.04.022.
4
The 2.2-Angstrom resolution crystal structure of the carboxy-terminal region of ataxin-3.ataxin-3羧基末端区域的2.2埃分辨率晶体结构。
FEBS Open Bio. 2016 Feb 18;6(3):168-78. doi: 10.1002/2211-5463.12029. eCollection 2016 Mar.
5
Enhanced molecular mobility of ordinarily structured regions drives polyglutamine disease.普通结构区域增强的分子流动性驱动聚谷氨酰胺疾病。
J Biol Chem. 2015 Oct 2;290(40):24190-200. doi: 10.1074/jbc.M115.659532. Epub 2015 Aug 10.
6
A tale of a tail: Structural insights into the conformational properties of the polyglutamine protein ataxin-3.尾巴的故事:多聚谷氨酰胺蛋白ataxin-3构象特性的结构见解
Int J Mass Spectrom. 2013 Jul 1;345-347:63-70. doi: 10.1016/j.ijms.2012.08.032.
7
Examination of Ataxin-3 (atx-3) Aggregation by Structural Mass Spectrometry Techniques: A Rationale for Expedited Aggregation upon Polyglutamine (polyQ) Expansion.利用结构质谱技术检测ataxin-3(atx-3)聚集:聚谷氨酰胺(polyQ)扩增后加速聚集的原理
Mol Cell Proteomics. 2015 May;14(5):1241-53. doi: 10.1074/mcp.M114.044610. Epub 2015 Feb 19.
8
Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors.离子淌度光谱-质谱法确定了胰淀素淀粉样蛋白形成过程中的寡聚中间体以及抑制剂的作用模式。
J Am Chem Soc. 2014 Jan 15;136(2):660-70. doi: 10.1021/ja406831n. Epub 2013 Dec 30.
9
The conformational ensemble of the disordered and aggregation-protective 182-291 region of ataxin-3.ataxin-3蛋白182 - 291区域无序且具有聚集保护作用的构象集合。
Biochim Biophys Acta. 2013 Nov;1830(11):5236-47. doi: 10.1016/j.bbagen.2013.07.007. Epub 2013 Jul 25.
10
The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases.聚集抑制剂肽QBP1作为聚谷氨酰胺神经退行性疾病的治疗分子
J Amino Acids. 2011;2011:265084. doi: 10.4061/2011/265084. Epub 2011 Jun 30.